LymphedemaV1, PubMed, Checkpoint, bibRecord, 000040

Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.

Identifieur interne : 000040 ( PubMed/Checkpoint ); précédent : 000039; suivant : 000041

Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.

Auteurs : Lkay Özer [Turquie] ; Cengiz Karaçin [Turquie] ; Esra Ad En [Turquie] ; Galip Güz [Turquie] ; Mehmet Ali Gürer [Turquie]

Source :

Dermatologic therapy [ 1529-8019 ] ; 2017.

RBID : pubmed:27862787

Abstract

Hidradenitis suppurativa, known as acne inversa, is a relapsing and chronic inflammatory skin disease affecting the skin folds. During the chronic course of the disease many local complications like fistulae to other tissues or systemic complications including anemia, secondary amyloidosis, lymphedema, nephrotic syndrome, artropathy may take place. Amyloid A amyloidosis is a rare complication of hidradenitis suppurativa, which has been described in a limited number of case reports. Herein, we present such a patient that had developed AA amyloidosis during the course of hidradenitis suppurativa. Both AA amyloidosis and hidradenitis suppurativa have responded to infliximab therapy which was shown by clinical recovery and by the improvement in renal functions.

DOI: 10.1111/dth.12445
PubMed: 27862787

Affiliations:

Turquie

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000510
to stream PubMed, to step Curation: 000510

Links to Exploration step

pubmed:27862787

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.</title>
<author><name sortKey="Ozer,  Lkay" sort="Ozer,  Lkay" uniqKey="Ozer  " first=" Lkay" last="Özer"> Lkay Özer</name>
<affiliation wicri:level="1"><nlm:affiliation>Meram Faculty of Medicine, Department of Dermatology, Necmettin Erbakan University, Konya, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Meram Faculty of Medicine, Department of Dermatology, Necmettin Erbakan University, Konya</wicri:regionArea>
<wicri:noRegion>Konya</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Karacin, Cengiz" sort="Karacin, Cengiz" uniqKey="Karacin C" first="Cengiz" last="Karaçin">Cengiz Karaçin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Nephrology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ad En, Esra" sort="Ad En, Esra" uniqKey="Ad En E" first="Esra" last="Ad En">Esra Ad En</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Dermatology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guz, Galip" sort="Guz, Galip" uniqKey="Guz G" first="Galip" last="Güz">Galip Güz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Nephrology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ali Gurer, Mehmet" sort="Ali Gurer, Mehmet" uniqKey="Ali Gurer M" first="Mehmet" last="Ali Gürer">Mehmet Ali Gürer</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Dermatology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27862787</idno>
<idno type="pmid">27862787</idno>
<idno type="doi">10.1111/dth.12445</idno>
<idno type="wicri:Area/PubMed/Corpus">000510</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000510</idno>
<idno type="wicri:Area/PubMed/Curation">000510</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000510</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000510</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000510</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.</title>
<author><name sortKey="Ozer,  Lkay" sort="Ozer,  Lkay" uniqKey="Ozer  " first=" Lkay" last="Özer"> Lkay Özer</name>
<affiliation wicri:level="1"><nlm:affiliation>Meram Faculty of Medicine, Department of Dermatology, Necmettin Erbakan University, Konya, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Meram Faculty of Medicine, Department of Dermatology, Necmettin Erbakan University, Konya</wicri:regionArea>
<wicri:noRegion>Konya</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Karacin, Cengiz" sort="Karacin, Cengiz" uniqKey="Karacin C" first="Cengiz" last="Karaçin">Cengiz Karaçin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Nephrology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ad En, Esra" sort="Ad En, Esra" uniqKey="Ad En E" first="Esra" last="Ad En">Esra Ad En</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Dermatology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guz, Galip" sort="Guz, Galip" uniqKey="Guz G" first="Galip" last="Güz">Galip Güz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Nephrology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ali Gurer, Mehmet" sort="Ali Gurer, Mehmet" uniqKey="Ali Gurer M" first="Mehmet" last="Ali Gürer">Mehmet Ali Gürer</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Dermatology, Gazi University Faculty of Medicine, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Dermatologic therapy</title>
<idno type="eISSN">1529-8019</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Hidradenitis suppurativa, known as acne inversa, is a relapsing and chronic inflammatory skin disease affecting the skin folds. During the chronic course of the disease many local complications like fistulae to other tissues or systemic complications including anemia, secondary amyloidosis, lymphedema, nephrotic syndrome, artropathy may take place. Amyloid A amyloidosis is a rare complication of hidradenitis suppurativa, which has been described in a limited number of case reports. Herein, we present such a patient that had developed AA amyloidosis during the course of hidradenitis suppurativa. Both AA amyloidosis and hidradenitis suppurativa have responded to infliximab therapy which was shown by clinical recovery and by the improvement in renal functions.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27862787</PMID>
<DateCreated><Year>2016</Year>
<Month>11</Month>
<Day>18</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>04</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-8019</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>30</Volume>
<Issue>2</Issue>
<PubDate><Year>2017</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Dermatologic therapy</Title>
<ISOAbbreviation>Dermatol Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.12445</ELocationID>
<Abstract><AbstractText>Hidradenitis suppurativa, known as acne inversa, is a relapsing and chronic inflammatory skin disease affecting the skin folds. During the chronic course of the disease many local complications like fistulae to other tissues or systemic complications including anemia, secondary amyloidosis, lymphedema, nephrotic syndrome, artropathy may take place. Amyloid A amyloidosis is a rare complication of hidradenitis suppurativa, which has been described in a limited number of case reports. Herein, we present such a patient that had developed AA amyloidosis during the course of hidradenitis suppurativa. Both AA amyloidosis and hidradenitis suppurativa have responded to infliximab therapy which was shown by clinical recovery and by the improvement in renal functions.</AbstractText>
<CopyrightInformation>© 2016 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Özer</LastName>
<ForeName>İlkay</ForeName>
<Initials>İ</Initials>
<AffiliationInfo><Affiliation>Meram Faculty of Medicine, Department of Dermatology, Necmettin Erbakan University, Konya, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Karaçin</LastName>
<ForeName>Cengiz</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Adışen</LastName>
<ForeName>Esra</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Güz</LastName>
<ForeName>Galip</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ali Gürer</LastName>
<ForeName>Mehmet</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>11</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Dermatol Ther</MedlineTA>
<NlmUniqueID>9700070</NlmUniqueID>
<ISSNLinking>1396-0296</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hidradenitis suppurativa</Keyword>
<Keyword MajorTopicYN="N">infliximab</Keyword>
<Keyword MajorTopicYN="N">systemic amyloidosis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>07</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>10</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>11</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>11</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>11</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27862787</ArticleId>
<ArticleId IdType="doi">10.1111/dth.12445</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Turquie</li>
</country>
</list>
<tree><country name="Turquie"><noRegion><name sortKey="Ozer,  Lkay" sort="Ozer,  Lkay" uniqKey="Ozer  " first=" Lkay" last="Özer"> Lkay Özer</name>
</noRegion>
<name sortKey="Ad En, Esra" sort="Ad En, Esra" uniqKey="Ad En E" first="Esra" last="Ad En">Esra Ad En</name>
<name sortKey="Ali Gurer, Mehmet" sort="Ali Gurer, Mehmet" uniqKey="Ali Gurer M" first="Mehmet" last="Ali Gürer">Mehmet Ali Gürer</name>
<name sortKey="Guz, Galip" sort="Guz, Galip" uniqKey="Guz G" first="Galip" last="Güz">Galip Güz</name>
<name sortKey="Karacin, Cengiz" sort="Karacin, Cengiz" uniqKey="Karacin C" first="Cengiz" last="Karaçin">Cengiz Karaçin</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000040 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000040 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:27862787
   |texte=   Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:27862787" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.

Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki